Johnson & Johnson acquires Alios BioPharma

Johnson & Johnson acquires Alios BioPharma

Johnson & Johnson acquires private biotechnology company Alios BioPharma in cash deal for $1.75 Billion. Alios is developing treatment for RSV – respiratory syncytial virus. Nowdays it is in Phase 2 studies. “We are excited that this acquisition will enable us to explore treatment options for a number of viral infections, including RSV, the last…

Read More...

Encana acquires Athlon for $5.9 Billion

Encana acquires Athlon for $5.9 Billion

One of biggest natural gas and oil producers in Canada Encana Corporation acquires Athlon Energy Inc. for $5.9 Billion “This transformative acquisition further accelerates our strategy and provides us with a prime position in what is widely acknowledged as one of North America’s top oil plays,” Doug Suttles, Encana’s chief executive, said in a statement….

Read More...

Mitsubishi acquires Cermaq

Mitsubishi acquires Cermaq

Mitsubishi Corporation acquires Norwegian state-controlled salmon producer Cermaq for $1.39 Billion (NOK 8.88 billion) On Monday Mitsubishi said that it agreed to acquire Cermaq in cash deal for 96 kroner per share ($15.11). It’s 14.3 percent premium to Cermaq’s closing prince on Friday. “The offer recognizes the financial and strategic value of Cermaq and delivers an attractive…

Read More...

MGM acquires 55 % of Mark Burnett’s vaious production ventures

MGM acquires 55 % of Mark Burnett’s vaious production ventures

Metro Goldwyn Mayer, which 17th of the April celebreated 90th Anniversary, had acquired a majority stake in One Three Media, known reality show like The Voice, Survivor, Shark Tank or The Apprentice. The new division will be part LightWorkers Media, comapny making religious-themed programming. The Hearst Corporation will stay minority owner in One Three Media…

Read More...

Merck of Germany acquires Sigma-Aldrich for $17 Billion

Merck of Germany acquires Sigma-Aldrich for $17 Billion

Merck of Germany agreed to acquie Sigma-Aldrich, the life sciences company, for $17 billion.  Merck called this transaction as a “quantum leap” for its life sciences business.  “The combination of Merck and Sigma-Aldrich will secure stable growth and profitability in an industry that is driven by trends such as the globalization of research and manufacturing,”…

Read More...